ArcticZymes Technologies ASA (OSL:AZT) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSL:AZT ArcticZymes Technologies ASA OSL:AZT
78 GF Score
Price kr18.95
GF Value kr24.75
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is ArcticZymes Technologies ASA Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

OSL:AZT vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, ArcticZymes Technologies ASA's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ArcticZymes Technologies ASA Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ArcticZymes Technologies ASA's Short Interest distribution charts can be found below:

* The bar in red indicates where ArcticZymes Technologies ASA's Short Interest falls into.


OSL:AZT
78GF Score
ArcticZymes Technologies ASA OSL:AZT
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is ArcticZymes Technologies ASA (OSL:AZT) Overvalued in 2026?

Based on GuruFocus' analysis, ArcticZymes Technologies ASA stock appears to be undervalued. The current stock price of kr18.95 is trading 23.4% below its estimated GF Value™ of kr24.75. GuruFocus considers ArcticZymes Technologies ASA to be Modestly Undervalued.

Key valuation signals for OSL:AZT:

  • Short Interest:
  • GF Value™: kr24.75 vs. price of kr18.95 (23.4% below fair value)
  • GF Score™: 78/100 with 1 warning sign

No single metric tells the full story. See the OSL:AZT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ArcticZymes Technologies ASA Business Description

Other Exchanges BIOTECO:Sweden0DRV:UK
Address Sykehusveien 23, Tromso, NOR, 9294
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments, Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA followed by Lithuania, Norway, Germany, France, Italy, UK, Other countries in Europe, and Rest of world.
78GF Score

Get the complete analysis for OSL:AZT

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr18.95
Price
kr24.75
GF Value